May 30, 2020

5 min read

Opinions expressed by Entrepreneur contributors are their own.

Since the outbreak began, it can seem like it’s harder than ever to stand out amidst all the noise. We’re writing posts that people don’t read, hosting live streams people don’t attend, and running ads that people don’t click on anymore.

And when you combine a decrease in engagement, a loss of income, and a nagging feeling that you’re not even making a contribution, it’s only natural that the internal strife just builds and builds.

This lack of engagement, money, and purpose very much defined my life a few years ago. I had developed skills as a communication and messaging expert, yet I was driving for Lyft just to make ends meet. I knew I had valuable skills, but no one else did.

Then, a couple of years ago, I made a shift in my marketing

In a major relief for borrowers, the (RBI) on Friday lowered the repo rate by 40 basis points from 4.4 per cent to 4 per cent. The reverse repo rate was also reduced to 3.35 per cent. These rate cuts were made in order to limit the impact of the nationwide on the economy. Borrowers, especially those whose are linked to external benchmarks like the repo rate can rejoice. The apex bank last cut the rates in its March 2020 in an advanced monetary policy review. In total, it has cut the repo rate by 75 bps since the started.

Note: 100 basis points equal one percentage point.

Here’s how borrowers are likely to gain from the RBI’s rate cut, depending of whether and how much banks and non-banking lenders pass on the benefits to customers.

Impact on

Chief Minister Edappadi K Palaniswami has decided to reach out to 13 global heads of prominent companies in the electronic sector including Apple CEO Tim Cook and Amazon CEO Jeff Bezos, inviting them to invest in the state and offering the state government’s support in the form of customised incentive packages.

The move is aimed at cashing in on the opportunities arising with companies planning to exit from countries like China and looking to relocate their manufacturing activities to countries like India.

He will be writing directly to the heads of these companies, including Samsung’s president and CEO Kim Hyun Suk and HP’s CEO Enrique Lores, among others, said a government announcement.

ALSO READ: Tamil Nadu signs MoUs worth over Rs 15,000 crore to generate 47,000 jobs

“The letters outline the investment attractiveness and inherent advantages

India’s largest drug maker Sun Pharmaceutical Industries is getting ready to start the trials on a few drugs that have emerged as potential treatment candidates for Covid-19. This includes an anti-coagulant and anti-inflammatory drug nafamostat and another plant-based dengue drug candidate that was developing along with government research institutes.

stock was up 3.5 per cent on BSE on Friday.

On Friday, said that it received the nod from the country’s drug regulator to initiate a clinical trial with nafamostat mesilate in Covid-19 patients. These will be phase II clinical trials on about 40 patients. This drug is approved in Japan for improvement of acute symptoms of pancreatitis as well as for treatment of DIC (Disseminated Intravascular Coagulation).

Basically, it is an anti-coagulant drug that has potential anti-inflammatory and anti-viral activities against Covid-19.

ALSO READ: Vodafone Idea